Biomarkers of Ischemia: Xanthine, Hypoxanthine and Inosine Levels During Carotid Stenting Procedures

Sponsor
Virginia Commonwealth University (Other)
Overall Status
Completed
CT.gov ID
NCT01639534
Collaborator
(none)
10
1
31.3
0.3

Study Details

Study Description

Brief Summary

The purpose of the study is to determine if a new blood test can help the doctor determine if there is brain injury or ischemia. Ischemia occurs when not enough oxygen gets to the brain. In this study the investigators are analyzing your blood for a new test that might help doctors decide if symptoms are from a neurologic problem.

Detailed Description

We will compare a new blood test with routine tests that the doctor will order as part of your normal care. This study will measure new biomarkers (biomarker is a specific distinguishing feature used to measure or indicate the effects or progress of a disease or condition) of neurologic stress called xanthine, hypoxanthine, and inosine. Blood will be drawn as a part of the study to measure these biomarker levels in your blood. This blood will be analyzed i the laboratory at Virginia Commonwealth University and possibly at a future date at another institution. No names will be associated with the blood sample

Study Design

Study Type:
Observational
Actual Enrollment :
10 participants
Observational Model:
Case-Only
Time Perspective:
Other
Official Title:
Biomarkers of Ischemia: Xanthine, Hypoxanthine and Inosine Levels During Carotid Stenting Procedures
Study Start Date :
Mar 1, 2011
Actual Primary Completion Date :
Oct 9, 2013
Actual Study Completion Date :
Oct 9, 2013

Arms and Interventions

Arm Intervention/Treatment
Biomarkers, Carotid Stenting, Blood sample

Subjects requiring Carotid Stenting Procedure at Virginia Commonwealth University/Medical College of Virginia Health Systems

Outcome Measures

Primary Outcome Measures

  1. Biomarkers of Ischemia: Levels of Xanthine, Hypoxanthine and Inosine during Carotid Stenting Procedures [analysis will occur after all samples collected]

    To compare a new blood test with can help the doctor determine if there is a brain injury or ischemia, The study will measure new biomarkers of neurologic stress called xanthine, hypoxanthine and inosine. Blood will be drawn as a part of the study to measure these biomarker levels in the blood. The blood will be analyzed in the laboratory at VCU.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Men and Women over age of 18 non

  • Women who are not pregnant

  • Subject who are not prisoners

  • Subjects presenting to the operation room for a Carotid artery stenting procedure

  • Hemoglobin greater than or equal to 11mg/dl

  • Subjects who speak english

  • Subjects 18 years of age or older

Exclusion Criteria:
  • Hemoglobin less than 11mg/dl

  • Women who are pregnant

  • Children under age of 18

  • Prisoners

  • Non English

Contacts and Locations

Locations

Site City State Country Postal Code
1 Virginia Commonwealth University Richmond Virginia United States 23298

Sponsors and Collaborators

  • Virginia Commonwealth University

Investigators

  • Principal Investigator: Lynne Gehr, MD, Virginia Commonwealth University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Virginia Commonwealth University
ClinicalTrials.gov Identifier:
NCT01639534
Other Study ID Numbers:
  • HM12941
First Posted:
Jul 12, 2012
Last Update Posted:
Jul 31, 2018
Last Verified:
Jul 1, 2018
Keywords provided by Virginia Commonwealth University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 31, 2018